---
document_datetime: 2025-05-15 10:00:41
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rytelo-epar-procedural-steps-taken-scientific-information-after-information_en.pdf
document_name: rytelo-epar-procedural-steps-taken-scientific-information-after-information_en.pdf
version: success
processing_time: 2.977101
conversion_datetime: 2025-12-24 22:40:19.642701
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rytelo

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,please alsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber    | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | A.ADMINISTRATIVECHANGES-A.1 Change | 14/05/2025                          |                                          | SmPC,                           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000272668                     | in the name and/or address of the marketing authorisation holder- Accepted                                  |            |     | Labelling and PL   |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|
| Variation type IB / EMA/VR/0000262416 | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.z Other variation - Accepted | 28/04/2025 | N/A |                    |